2021
DOI: 10.1017/s0007114521000064
|View full text |Cite
|
Sign up to set email alerts
|

Abdominal obesity and risk of CVD: a dose–response meta-analysis of thirty-one prospective studies

Abstract: This meta-analysis aimed to study the relationship between abdominal obesity and the risk of cardiovascular disease (CVD) by waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR). We systematically searched PubMed, Embase and Web of Science. Prospective studies that estimated cardiovascular events by WC, WHR and WHtR were included in this study. Pooled relative risks with 95% confidence intervals were calculated using random-effects models. A total of 31 studies were included in t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
22
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(26 citation statements)
references
References 58 publications
4
22
0
Order By: Relevance
“…Central obesity, with the adipose tissue predominantly concentrated around the viscera, is considered to have an increased unfavorable effect on cardiovascular risk [56,57]. A recent meta-analysis of prospective studies evaluating the link between abdominal obesity and cardiovascular risk has shown a strong association between the parameters describing central obesity (waist circumference, waist:hip ratio, and waist:height ratio) and cardiovascular diseases (including ischemic heart disease, cerebrovascular disease) [58]. The deleterious effect of visceral adipose surplus appears to manifest itself even in otherwise normal-weight individuals (according to BMI values) which show evidence of excess abdominal adiposity (measured by waist circumference for example) [59].…”
Section: Central Obesity and Metabolically Healthy Obesitymentioning
confidence: 99%
“…Central obesity, with the adipose tissue predominantly concentrated around the viscera, is considered to have an increased unfavorable effect on cardiovascular risk [56,57]. A recent meta-analysis of prospective studies evaluating the link between abdominal obesity and cardiovascular risk has shown a strong association between the parameters describing central obesity (waist circumference, waist:hip ratio, and waist:height ratio) and cardiovascular diseases (including ischemic heart disease, cerebrovascular disease) [58]. The deleterious effect of visceral adipose surplus appears to manifest itself even in otherwise normal-weight individuals (according to BMI values) which show evidence of excess abdominal adiposity (measured by waist circumference for example) [59].…”
Section: Central Obesity and Metabolically Healthy Obesitymentioning
confidence: 99%
“…Estimation of the risk for metabolic disease and monitoring of conditions had been done so far, using the level of biochemical parameters, triglyceride, cholesterol, high-density lipoprotein and fasting serum glucose, and nonbiochemical, BMI and waist circumference, that also have rules in the risk assessment for cardiovascular diseases (especially central obesity) [21].…”
Section: Introductionmentioning
confidence: 99%
“…For example, sex- and age-specific cut-offs ( 18 , 19 ) complicate the use of BMI to define obesity in practice, and BMI does not accurately discriminate body fat distribution ( 20 ). In contrast, WC and WHtR are markers of abdominal adiposity that are more closely linked with metabolic disturbances ( 21 ), and more strongly associated with CVD outcomes ( 22 ) and all-cause mortality ( 23 ). Sex- and age-specific cut-offs of WC are also required to define central obesity, whereas WHtR is standardized for height and indirectly adjusts for the effect of age, which is a simple and pragmatic index to correctly assess central obesity ( 24 ).…”
Section: Introductionmentioning
confidence: 99%